Offen für Angebote

Central Laboratory Services for Clinical Trial

Frist:04 Nov 2026, 11:00 CET

Ausschreibungsinformationen

DE_BKMS

Leipzig, Deutschland

Art: services (tender)
Verfahren: Offenes Verfahren
Referenznummer: 24534bba-60b4-4899-b7a4-9d08ac3cb0bf
CPV: 85100000 Health services

The Federal Agency for Disruptive Innovation - SPRIND GmbH ("SPRIND") - aims to create new disruptive innovations from Germany. That means products, services and systems that make all our lives noticeably and sustainably…

better. To achieve this, SPRIND brings together new thinkers from science and business, people with outstanding ideas, special expertise, and passion. Hence, SPRIND provides an entrepreneurial environment that turns ideas into reality. The objective of BiconY Therapeutics GmbH, a SPRIND subsidiary

, is the development of a bispecific antibody combination for the treatment of solid tumours. The combination consists of proprietary, bispecific CD3 anti-bodies (bsAbCD3) and bispecific CD28 co-stimulators (BiCos), which, when used togethe

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen

Ähnliche Ausschreibungen

Gesundheit & Medizin Alle Ausschreibungen in Deutschland Gesundheit & Medizin in Deutschland Krankenhaus & Medizintechnik